Company: RNAC
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001453687-25-000099
Chunk: 91

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part II, Item 2
Chunk 91
---
Filed herewith101.LABInline XBRL Taxonomy Extension Label Linkbase Document---Filed herewith

42

Table of Contents

101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document---Filed herewith104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)---Filed herewith

* Certain annexes, schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally a copy of any omitted attachment to the SEC on a confidential basis upon request.    

43

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant in the capacities and on the dates indicated.

 CARTESIAN THERAPEUTICS, INC.  Date: August 7, 2025By:/s/ Carsten Brunn, Ph.D. Carsten Brunn, Ph.D. President and Chief Executive Officer, and Director(Principal Executive Officer)  Date: August 7, 2025By:/s/ Blaine Davis Blaine Davis Chief Financial Officer(Principal Financial Officer)

44